To identify further the surface proteins of the native virus, hepatitis B virus (HBV) particles purified from HBe antigen (Ag)-positive human sera were used as immunogens to produce murine monoclonal antibody (MAb)-secreting hybridomas. The specific binding of antibodies to the HBV envelope (env) proteins was determined in indirect radioimmunoassay and by Western blot analysis. Six MAbs directed against major hepatitis B surface antigen (HBsAg) recognized conformational epitopes on S proteins (P24~/GP27~). Three preS2-specific MAbs reacted with the middle env proteins (GP33s/GP36 s) in the 22 nm HBsAg spherical particles. One MAb, F222, was found to react specifically with the two very large (VL) HBV surface proteins with Mr 54K and 66K. The epitope recognized by F222 was located on the protruding N terminus which, in the assembled virus particles, was readily split off by trypsin or V8 protease treatment. The presence of these VL proteins appeared to correspond to the presence of the large env proteins (P39s/GP429. The data described here indicate that F222 probably recognized an assembled topographic site which could be involved in virus entry into hepatocytes. Moreover, our results suggest that the preS-coded part of the HBV env proteins, which is sensitive to proteases in vitro, could be unstable in vivo and stabilized by immunoglobulins.
INTRODUCTION
The hepatitis B virus (HBV) envelope (env) proteins are derived from one continuous open reading frame of the HBV genome, the so-called S/preS region designated as the env gene (Tiollais et al., 1985) . There are three co-carboxy-terminal translation products differing in size by their amino-terminal extensions. The major surface antigen [hepatitis B surface antigen (HBsAg)] consists of a polypeptide of 226 amino acids (P24 s) and its glycosylated form (GP27 s) encoded by the S gene. In addition, the preS2/S subregions coded for the middle (M) proteins (GP33 S and GP36 S) with 55 additional amino acids at the N terminus (Stibbe & Gerlich, 1982) , and the preSl/preS2/S subregions coded for the large (L) protein P39 s and its glycosylated form GP42 s with a further additional 108 to 119 N terminal amino acids, depending on the antigenic subtype of HBV (ay or ad) (Heermann et al., 1984) . The preS2-encoded sequence carries speciesspecific binding sites for polymerized human serum albumin (pHSA) (Machida et al., 1984) and it has been postulated that the attachment of HBV to hepatocytes is mediated by pHSA reacting with both preS2 sequences of HBV and albumin receptors on hepatocytes (Trevisan et al., 1981) . The preS1 translation product may also play a role in hepatocyte receptor binding and, recently, Neurath et al. (1986 b) showed that the preS1 sequence is essential for recognition of HEp G2 cell receptors by HBV. The major S proteins are present in 22 nm spherical and filamentous forms of HBsAg as well as in the envelope of the complete virions. In contrast, preS1 proteins are essential components only of the HBsAg filaments and the virus itself (Heermann et al., 1984; Takahashi et al., 1986) .
In an attempt to define the importance of preS proteins, we investigated the expression of the various HBsAg proteins in different HBV isolates obtained from hepatitis B e antigen (HBeAg)-positive plasmas. By using monoclonal antibodies (MAbs) directed to preS2 sequences of the HBV env proteins (Neurath et al., 1986a; Budkowska et al., 1986) , and one MAb (F222) recognizing very large (VL) surface antigen polypeptides with Mr of 54000 (54K) and 66000 (66K), which were found to contain preS1 epitopes, a variability in the expression of preS antigens was observed. These studies confirmed that HBV possesses a cluster of pi'eS-related env proteins and revealed that the largest surface antigen proteins in the 50K to 70K range, specifically identified by our MAb F222, probably represent the building blocks of the viral peplomer, the most peripheral structure of the HBV particle. Such virion envelope components may constitute the HBV fusion proteins playing an important role in the initial stages of viral infection and in the production of virus-neutralizing antibodies.
METHODS
Virus isolates and preparations. Four isolates of HBV were used in this study: WI from plasma of an asymptomatic chronic carrier of HBsAg/adw2 and RE, LEF, and BAY from plasmapheresis of patients with polyarteritis nodosa (PAN) associated with HBs/ay antigenaemia. All samples were positive for HBeAg, HBV DNA and DNA polymerase. HBV particles were purified by a succession of steps involving isopycnic and rate zonal centrifugations in a sucrose density gradient (Petit et al., 1985) .
Limited proteolytic digestion of purified HBV. Purified preparations of HBV were incubated with the endoproteinase GIu-C from Staphylococcus aureus V8, called V8 protease (Type XVII from Sigma) for 24 h at 37 °C in 0.1 M-Tris-HC1 pH 7.4 at a final concentration of 250 ~tg/ml. The digested viral particles were separated from the enzyme by centrifugation in a sucrose gradient (20 to 60~) for 6 h at 284000 g, followed by dialysis overnight at 4 °C against 0.01 M-Tris-HC1 pH 7.4. In parallel experiments, virus preparations were digested with TPCK-trypsin (Type XIII from Sigma) for 3 h at 37 °C at the same final concentration. The reaction was stopped with sample buffer (see below) for Western blotting analysis.
Preparations of MAbs. MAbs were obtained by immunization of BALB/c mice with native HBV particles purified from a chronic HBsAg/ay carrier (RE), as well as with serum-derived 22 nm HBsAg particles (subtype ay) and with recombinant HBsAg particles of the ayw subtype synthesized in Chinese hamster ovary (CHO) cells, transfected with the S and preS regions of HBV DNA (Michel et al., 1984) . Immunization, cell fusion and the production of ascites fluid were carried out as described by Budkowska et al. (1986) . Hybridoma culture supernatant fluids were assayed for the presence of specific antibodies by indirect radioimmunoassay (RIA) using native HBV particles (used for immunization) as the solid-phase antigen and 125I-labelled F(ab')2 fragment of sheep anti-mouse Ig (Amersham) as a tracer second antibody. Hybridoma clones negative for anti-HBs by the Ausab RIA (Abbott Laboratories, North Chicago, Ill., U.S.A.) were tested for the secretion of antibody to preS antigens by Western blotting using dissociated virus proteins as antigenic probes . MAbs F 124, F376, F52 and F222 were selected for the present studies. The P39 s and GP42~-specific MAb, MA 18/7, was supplied by W. Gerlich.
Western immunoblotting assay. Untreated or digested virus preparations were incubated overnight at 37 °C, followed by 10 min at 60 °C in the presence of 2 ~ (w/v) SDS and 5 % (v/v) 2-mercaptoethanol (SDS PAGE sample buffer), and then subjected to electrophoresis in 12-5 ~ polyacrylamide gels according to Laemmli (1970) . Proteins were transferred onto nitrocellulose filters (Schleicher & Schiill) in Tris glycine buffer (25 mM-Tris, 192 mM-glycine pH 8.3) and 20 ~ methanol (v/v) using a Trans-Blot cell (Bio-Rad) as described by Burnette (1981) . The filters were saturated with 3~ (w/v) bovine serum albumin and 10~ (v/v) foetal calf serum in TN buffer (0.01 M-Tris-HC1, 0.14 M-NaC1 pH 7-2) overnight at 4 °C (or 1 h at 37 °C) to prevent non-specific protein binding. The filters were then incubated for 3 h at 40 °C with rabbit or human polyclonal IgGs, and with murine MAbs (approx. 1 mg protein/ml) at a 1:100 to 1:200 dilution in blocking buffer. The binding of specific antibodies was detected by incubation (1 h at 40 °C) with 1251-labelled F(ab')2 fragments of anti-rabbit, anti-human or anti-mouse Ig from Amersham (0.5 × 106 to 1 × 106 c.p.m, per gel lane). The immune reaction was visualized by autoradiography.
Other assays. HBsAg activity was determined by a RIA test involving rabbit polyclonal IgG to serum HBsAg both in the solid phase as catcher and radiolabelled as tracer. HBV-associated endogenous DNA polymerase activity was analysed by the method described by Alberti et al. (1981) . HBV DNA was determined by hybridization according to Scotto et al. (1983) .
Electron microscopy. Untreated or V8 protease-digested HBV preparations (5 ~tl) were applied to charged carbon-coated copper grids, washed, stained with 0.5~ uranyl acetate and viewed with a Jeol 100 CX electron microscope. 
RESULTS
The six S-specific MAbs obtained by immunization with HBV particles, serum-derived HBsAg particles or CHO/HBsAg particles (containing approx. 35~o preS2 protein; Michel et al., 1984) gave negative reactions with dissociated HBsAg polypeptides on immunoblotting (Table 1 ). All recognized conformational epitopes on S proteins (P24 s and GP27s). Three MAbs (F124, F376 and F52) were found to be reactive with the M proteins (P31 s, GP33 s and GP36 s) (Table 1 ). F124 and F376 were characterized previously (Neurath et al., 1986a; and were shown to be directed against two distinct epitopes localized at the N terminal part of the M protein(s). The epitope specificity of F52 was determined by tryptic proteolysis of HBV proteins and immunological analysis of the peptides on blots (Fig. 1) . As described in detail elsewhere , F52 also reacted with an HBsAg polypeptide with a Mr of 66K in HBV (Fig. 1 a, b , lanes 1) and its reactivity on immunoblotting was not completely abolished by trypsin or V8 protease treatment of the antigen (Fig. 1 b, lanes 2 and 3) . Thus, the epitope recognized by F52 seemed to be localized on the C terminal end of the preS2 sequence (residues 167 to 174) proximal to the S region (Fig. lc) . Moreover, additional amino acid residues present in the 66K HBsAg polypeptide could contribute to the binding of F52. It is interesting to note that a 14.5K band resulting from trypsin cleavage was recognized by the MAb F52, but not by a polyclonal rabbit anti-HBs serum (Fig. 1 a, b, lanes 2) .
One other IgG1 MAb designated F222 was obtained by immunization with subtype ay HBV particles from human serum, and showed a high binding activity to purified native virus as determined by indirect RIA (titre > 10-9). The binding of F222 was specifically inhibited by purified virions (antigen limit dilution approx. 10-7), and was extremely sensitive to trypsin or V8 protease digestion of the virus particles. No reactivity was observed with the CHO/HBsAg particles in RIA or with the dissociated S and preS2 proteins in Western blot (results not shown). It is important to note that normal human serum (NHS) without viral markers inhibited the F222 antibody binding to HBV by 50~ at a dilution of approx. 1:80. The inhibitory activity of the serum was lost by centrifugation and after storage at 4 °C. Denatured albumin associated with immunoglobulins was identified in NHS as cross-reacting with F222 (results not shown).
When the MAb F222 was tested against HBV surface proteins to determine its polypeptide specificity, we found that it reacted weakly with a 39K polypeptide believed to be the L protein of the HBV envelope, and strongly bound to the 54K and 66K HBV proteins, which were clearly detected by polyclonal rabbit anti-HBs serum (Fig. 2) . As previously shown, F222 was not reactive with either monomeric and polymerized human albumin or with 7-, c~-and ~t-chains of Igs . We conclude that F222 specifically recognized the VL surface components of the HBV envelope. In order to characterize further the virus-specific surface proteins, the purified preparations of HBV subtype ay (RE, BAY, LEF) and a d w 2 (WI) were broken into constituent polypeptides, and Western blot experiments were performed using polyclonal antibodies and the MAbs previously described (F 124, F376, F52 and F222) . By using polyclonal rabbit anti-HBs or human anti-HBe/c IgGs, all preparations showed a strong reactivity with anti-HBs IgG at the positions of 23K and 26K, and with anti-HBe/c IgG at the position of 22K. The 23K and 26K bands corresponded to the S proteins (P24 s and GP27s), and the band of 22K to the major core protein of HBV (Fig. 3a, b, lanes 1 and 5) . In addition, polyclonal anti-HBs IgGs strongly reacted with proteins in the 31K to 39K range as preS proteins of the HBV env and revealed two other bands at 54K and 66K in the RE sample (Fig. 3a, lane 1) . The content of 33K/36K polypeptides was clearly much lower in the W I sample, and a band of 41K was recognized by both anti-HBs and . Lanes 2 and 4 were probed with normal rabbit and human IgGs, respectively, as-controls. The antibody binding to the transferred proteins was detected with 125I-labelled anti-rabbit or anti-human Ig F(ab') 2 fragment. Virus material was dissociated as described in Fig. 1 .
anti-HBe/c IgGs (Fig. 3b, lanes 1 and 5) . The two HBsAg polypeptides at 54K and 66K in the RE sample were also revealed by using a polyclonal rabbit anti-preS(12-32) serum provided by A. R. Neurath (Neurath et al., 1985) , (Fig. 3a, lanes 3) , suggesting the presence of preS1 sequence(s) on these VL components of HBV.
HBV surface proteins were then tested for binding with MAbs directed to preS2 sequences (results not shown). A strong reactivity with F124, F376 and F52 was only observed in the RE sample, which contained preS polypeptides (31K to 39K, Fig. 3a ) in large quantities. In fact, this purified HBV preparation was found to be contaminated by approx. 25 nm HBsAg empty Fig. 4 . Immunoblotting of surface proteins from four HBV isolates (lanes 1 to 3, Wl; lanes 4 to 7, RE; lanes 8 to 11, BAY; lanes 12 to 15, LEF) with MAb F222 (lanes 2, 5 to 9, 12 and 13) compared to MA 18/7 (lanes 3, 4, 10, 11, 14 and 15). Untreated (lanes 1 to 5, 9, 10, 13 and 14), trypsin-treated (lanes 6, 8, 11, 12 and 15) or V8 protease-digested (lane 7) virus samples were tested. Lane 1, the transferred HBV proteins were reacted with the IgG from control ascites fluid. The antibody was detected with ~5I-labelled anti-mouse Ig F(ab')~ fragment. M~ values given are x 10 -3. z Fig. 5 . Electron micrographs of a native (a) or V8 protease digested (b) HBV particle from the RE preparation. The V8-treated virus preparation was ultracentrifuged in a sucrose gradient (20 to 60~) for 6 h at 284000 g. Fraction 5 (at 36~ sucrose, c to f) and fraction 3 (at 20~ sucrose, g and h) were subjected to electron microscopical examination. Bar markers represent 10 nm for a and b, 50 nm for cto h. spherical particles by means of electron microscopical examination, which could be responsible for such a high preS2 reactivity. Five other purified HBV preparations (subtype adw2 or ay) rich in 42 nm particles positive for D N A polymerase activity and HBV D N A , were found to be unreactive with F124 and F376 in Western blot experiments. Four of these preparations however contained the preS1 polypeptides, detected by M A 18/7 (Heermann et al., 1984) (see untreated BAY and L E F samples in Fig. 4, lanes 10 and 14) . As illustrated in Fig. 4 , the different HBV preparations which reacted with F222 against the HBsAg proteins at 54K and 66K, reacted in parallel with M A 18/7 (see RE, BAY and L E F samples). The reactivity of F222 was however more sensitive to trypsin digestion than that of M A 18/7 (BAY sample, Fig.  4 ). These results revealed that the expression of the VL surface proteins, P54 s and P66 s, correlated well with the expression of the preS1 sequence on the surface of virus particles. An intriguing finding is that these VL components of HBV seem to be displayed most abundantly in HBV particles purified from HBsAg chronic carriers with PAN e.g. RE, BAY, LEF samples and others (PEI, LIS) compared to asymptomatic carriers as WI sample (and RI). Thus, the external disulphide bond-independent specificities recognized by F222 and anti-preS1 MAbs were split off by proteases in vitro, contrary to HBsAg. This suggests a possible high instability of prominent sequences of HBV surface components.
In this context, the effect of V8 protease treatment on the virus morphology was studied by means of electron microscopy. Fig. 5(a) and (b) show that a V8 protease-treated virion had a loose structure with an increased diameter of 50 nm, thereby indicating a destabilization of the native HBV env structure. Microscopical examination of each fraction obtained after rate-zonal sedimentation in sucrose gradient of the digested virus particles revealed the appearance of tubular forms with a diameter of 25 to 30 nm and a maximal length of 250 nm, which split into 25 to 30 nm spherical particles recovered from the top of the sucrose gradient (Fig. 5 c to h ). Such an observation leads to the assumption that viral surface antigen filaments, which disclosed the same env protein composition as HBV (Heermann el al., 1984; Takahashi el al., 1986) , could be generated from the complete virions by limited proteolysis.
DISCUSSION
Monoclonal antibodies are very useful for investigating surface characteristics of viral proteins (Yewdell & Gerhard, 1981 ; Orvell & Norrby, 1985) . In the present study, we provide evidence that the epitopes localized on the N terminal half of the preS2 sequence of the M proteins, GP33 s and GP36 s, and recognized by MAbs F124 and F376 (Neurath el al., 1986a (Neurath el al., , 1987 were not detected in 42 nm infectious virions containing preS1 proteins. This thereby indicates that amino acid residues about 125 to 165 in the preS2 sequence are not accessible to corresponding antibodies when preS 1 antigen(s) is expressed on the surface of the virus. In view of this finding, it is not surprising that rabbits vaccinated with a large surface antigencontaining recombinant vaccinia virus did not make antibodies to preS2 epitopes (Cheng el al., 1986) . PreS2 specific MAbs F124 and F376 thus reacted specifically with the M proteins, largely present in CHO/HBsAg particles (Budkowska el al., 1987) and in defective 25 nm HBsAg particles co-purified with HBV from HBeAg-positive sera. In contrast, MAb F52 was able to detect a preS2 epitope on HBV particles expressing preS1 antigens (result not shown). This is in agreement with the localization of the epitope recognized by F52 in the domain of amino acid residues preS (167 to 174) at the C terminus of the preS2 sequence proximal to HBsAg region. Notably, F52 was the only preS2-specific MAb strongly reacting with a 66K HBsAg protein. This finding may signify that two preS2 sequences located in close proximity would be required for an optimal epitope recognition by the MAb F52. The MAb F222 reacted with HBV-specific env proteins migrating at 54K and 66K in SDS-PAGE under strong reducing conditions. The epitope recognized by F222 has not yet been localized precisely. However, since the antibody weakly reacted with the L protein P39 s, we presume that it is specific for the N terminal amino acid long preS1 sequence associated with additional amino acid residues from another viral or host sequence in a complexed form. The largest components of the viral envelope specifically detected by F222 could therefore represent the building blocks of the HBV peplomer, the most peripheral structure of the particle. As it has been pointed out previously (Mishiro el al., 1980) that disulphide-bonded dimers of S proteins (P24 ~ and GP27 ~) form the fully antigenic structural subunit of the 22 nm HBsAg particles, we suggest that complexes of one P24 ~ and GP42 ~ molecule (containing all of the preS sequence) form the fully antigenic structural and functional subunit of the 42 nm HBV particles. This heterodimer would thus be resistant to dissociation under protein-denaturing conditions in polyacrylamide gels. In Fig. 6 , a schematic representation of the virus envelope structure is proposed. The transmembranous S protein(s) has an important role in virus assembly and stabilizes the viral envelope as a dimeric form (Fig.  6b) . The preS sequences could represent the virion peplomeric surface projections responsible for the attachment, and probably the fusion of the viral membrane with specific cellular membranes through pHSA or not (Fig. 6a) . Our microscopical examination of virus particles after V8 protease treatment suggests a polymerization of these prominent sequences to form the peplomer of HBV, which appears very sensitive to proteases and is easily released as tubular and afterwards 25 nm HBsAg forms. Such a degradative process could occur during the HBV purification procedure and explain the variability of the expression of preS-specificities on the surface of different HBV isolates. In PAN, the virus env antigens (as HBsAg) are associated with human serum IgM as HBV IgM complexes possibly leading to a lower sensitivity of preS sequences to proteases, and thus permitting their characterization. This hypothesis is supported by the recent findings of Irshad et at. (1987) showing that IgM further enhances the binding between HBsAg and pHSA through preS sequences which carry pHSA receptors. The MAb F222, which reacted with a 66K HBsAg polypeptide in HBV and cross-reacted with albumin-Ig complexes in NHS, may recognize the intimate association of HBsAg and albumin playing a role in the host-virus relationship. Thus, this MAb would provide a fruitful means to study the attachment of HBV to human hepatocytes.
